Quarterly report pursuant to Section 13 or 15(d)

Capitalization (Details)

v3.24.1.u1
Capitalization (Details)
Mar. 22, 2024
USD ($)
tranche
Mar. 31, 2024
$ / shares
shares
Mar. 29, 2024
USD ($)
Dec. 31, 2023
$ / shares
shares
Class A Common Stock        
Subsidiary, Sale of Stock        
Common stock, shares authorized (in shares) | shares   800,000,000   800,000,000
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001   $ 0.0001
Class V Common Stock        
Subsidiary, Sale of Stock        
Common stock, shares authorized (in shares) | shares   205,000,000   205,000,000
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001   $ 0.0001
Line of Credit | VGS 2 Promissory Note        
Subsidiary, Sale of Stock        
Funding provided $ 25,000,000      
Number of tranches (tranche) | tranche 2      
Percentage of upfront-fee 1.50%      
Line of Credit | Period One | VGS 2 Promissory Note        
Subsidiary, Sale of Stock        
Debt Instrument, Back End Fee 2.25%      
Line of Credit | Period Two | VGS 2 Promissory Note        
Subsidiary, Sale of Stock        
Debt Instrument, Back End Fee 4.50%      
Line of Credit | Period Four | VGS 2 Promissory Note        
Subsidiary, Sale of Stock        
Debt Instrument, Back End Fee 9.00%      
Line of Credit | Period Three | VGS 2 Promissory Note        
Subsidiary, Sale of Stock        
Debt Instrument, Back End Fee 6.75%      
Line of Credit | Option One | VGS 2 Promissory Note        
Subsidiary, Sale of Stock        
Interest rate 17.50%      
Paid in cash interest, percentage 8.00%      
Paid in kind interest, percentage 9.50%      
Line of Credit | Option Two | VGS 2 Promissory Note        
Subsidiary, Sale of Stock        
Paid in kind interest, percentage 17.50%      
Line of Credit | First tranche | VGS 2 Promissory Note        
Subsidiary, Sale of Stock        
Funding provided     $ 10,000,000  
Line of Credit | Second tranche | VGS 2 Promissory Note        
Subsidiary, Sale of Stock        
Funding provided     $ 15,000,000